文献速递间质性肺疾病

风湿性疾病中的肺部表现

Lung Manifestations in the Rheumatic Diseases.
PubMed 文献 · Chest · 2017-05-25

风湿性疾病的肺部病变诊断和管理面临独特挑战,是患者显著发病和死亡的原因。与特发性间质性肺炎不同,风湿病患者在全身性疾病背景下发生肺病,可能更难识别且治疗风险更大。尽管认识有所进步,但对自然史的理解仍显著不足,难以确定哪些患者疾病会进展并需要治疗。已知部分风湿病患者(如类风湿关节炎)的肺实质病变预后可类似特发性肺纤维化,而其他患者(如自身免疫性肌炎、系统性硬化症或未分化自身免疫过程)可有侵袭性炎症性肺病。

要点

  • 风湿性疾病患者肺病在全身性疾病背景下发生,识别更难且治疗风险可能更大。
  • 部分风湿病患者肺实质病变预后可类似特发性肺纤维化,如类风湿关节炎。
  • 自身免疫性肌炎、系统性硬化症或未分化自身免疫过程可伴侵袭性炎症性肺病。

核心结论

  • 风湿性疾病的肺部病变是患者显著发病和死亡的原因,诊断和管理面临独特挑战。
  • 对风湿病相关肺病自然史的理解仍显著不足,难以确定哪些患者会进展并需要治疗。

主要发现

  • 风湿病患者在全身性疾病背景下发生肺病,可能更难识别且治疗风险更大。
  • 部分风湿病患者(如类风湿关节炎)的肺实质病变预后可类似特发性肺纤维化。
  • 其他患者可在自身免疫性肌炎、系统性硬化症或未分化自身免疫过程中出现侵袭性炎症性肺病。

临床怎么用

  • 将肺健康视为风湿性疾病患者管理的基石,以提高识别高风险肺病及进展患者的能力。
  • 对高风险患者提供新兴治疗,以期改善结局和生活质量。

局限性

  • 对风湿病相关肺病的自然史仍缺乏理解,难以明确哪些患者会进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Lung ailments in rheumatic diseases present unique challenges for diagnosis and management and are a source of significant morbidity and mortality for patients. Unlike the idiopathic interstitial pneumonias, patients with rheumatic diseases experience lung disease in the context of a systemic disease that may make it more difficult to recognize and that may present greater risks with treatment. Despite recent advances in our awareness of these diseases, there is still a significant lack of understanding of natural history to elucidate which patients will have disease that is progressive and thus warrants treatment. What we do know is that a subset of patients with rheumatic disease experience parenchymal lung disease that can prognostically resemble idiopathic pulmonary fibrosis, such as in rheumatoid arthritis, and that others can have aggressive inflammatory lung disease in the context of autoimmune myositis, systemic sclerosis, or an undifferentiated autoimmune process. As we enter into a paradigm shift where we view lung health as a cornerstone of our care of patients with rheumatic diseases, we hopefully will improve our ability to identify those patients at highest risk for pulmonary disease and progression, and offer emerging treatments which will result in better outcomes and a better quality of life.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Doyle TJ, Dellaripa PF. Lung Manifestations in the Rheumatic Diseases. Chest. 2017. PMID: 28552544. doi:10.1016/j.chest.2017.05.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。